LAUSR

Background and aim: The main feature of sutureless aortic valve implantation is the speed of insertion, thus making implantation easier for the surgeon. As a result, cross clamp times and myocardial ischemia may be reduced. The combined procedures with CABG can be done with a short cross clamp time and cardiopulmonary bypass times. The aim of this study is to evaluate the effects of Percevall sutureless aortic valve prosthesis on surgical outcome in patients underwent combined procedures. Methods: We selected 36 consecutive patients who underwent Perceval implantation combined with coronary artery bypass and or other valve repair or replacement. Clinical, echocardiographic and in-hospital complications were obtained from chart review. Results: The mean age was 76.4 ± 9.8 (median 80) years old, 50% male. Eight of them were previous operated (Redo cardiac surgery22.2%), 3 treated with chronic kidney injury requiring dialysis (8.3%) and two had active endocarditis. Concomitant procedures included: coronary artery bypass (20 pts, 56%), mitral valve replacement or repair (11 pts, 31%), mitral and tricuspid repair/replacement (5 pts, 5%), tricuspid valve repair (1pt,3%) and mitral valve replacement associated to coronary artery bypass (2 pts, 5%). Patient operative risk, as estimated by logistic European System for Cardiac Operative Risk Evaluation, was 13.4 ± 12.8. Conclusions: Perceval sutureless aortic prosthesis facilitates reduced aortic cross-clamp and cardiopulmonary bypass times particularly in patients undergoing concomitant procedures allowing promising outcomes especially in high risk patients.